NCT02756130 2025-05-13
Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)
Jonsson Comprehensive Cancer Center
Phase 1/2 Withdrawn
Clinical Trials
3 trialsNCT01681368 2017-05-30
Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT01940172 2016-01-14
Study of Birinapant in Combination With Conatumumab in Subjects With Relapsed Ovarian Cancer
TetraLogic Pharmaceuticals
Phase 1 Completed